iShares Morningstar Mid-Cap Value ETF (IMCV)
NASDAQ: IMCV · Real-Time Price · USD
99.83
+0.41 (0.41%)
Nov 13, 2026, 4:00 PM EST - Market closed
| Assets | $1.29B |
| Expense Ratio | 0.06% |
| PE Ratio | 17.08 |
| Forward PE | 13.45 |
| Shares Out | 12.90M |
| Dividend | $1.83 (1.83%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 31.25% |
| Volume | 22,926 |
| Open | 99.99 |
| Previous Close | 99.42 |
| Day's Range | 99.26 - 99.99 |
| 52-Week Low | 77.65 |
| 52-Week High | 101.38 |
| Beta | 0.87 |
| Holdings | 272 |
| Inception Date | Jun 28, 2004 |
About IMCV
Fund Home PageThe iShares Morningstar Mid-Cap Value ETF (IMCV) is an exchange-traded fund that is based on the Morningstar US Mid Cap Broad Value index. The fund tracks a market cap-weighted index of US mid-cap stocks companies selected based on their value characteristics. IMCV was launched on Jun 28, 2004 and is issued by BlackRock.
Asset Class Equity
Category Mid-Cap Value
Region North America
Stock Exchange Nasdaq
Ticker Symbol IMCV
ETF Provider BlackRock
Index Tracked Morningstar US Mid Cap Broad Value Index
Top 10 Holdings
13.27% of assets| Name | Symbol | Weight |
|---|---|---|
| Automatic Data Processing, Inc. | ADP | 1.67% |
| Valero Energy Corporation | VLO | 1.47% |
| Phillips 66 | PSX | 1.43% |
| 3M Company | MMM | 1.31% |
| U.S. Bancorp | USB | 1.29% |
| Regeneron Pharmaceuticals, Inc. | REGN | 1.28% |
| The PNC Financial Services Group, Inc. | PNC | 1.26% |
| Elevance Health, Inc. | ELV | 1.23% |
| Mondelez International, Inc. | MDLZ | 1.16% |
| The Travelers Companies, Inc. | TRV | 1.15% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 15, 2026 | $0.51794 | Sep 18, 2026 |
| Jun 15, 2026 | $0.41796 | Jun 18, 2026 |
| Mar 17, 2026 | $0.35012 | Mar 20, 2026 |
| Dec 16, 2025 | $0.54033 | Dec 19, 2025 |
| Sep 16, 2025 | $0.42115 | Sep 19, 2025 |
| Jun 16, 2025 | $0.43838 | Jun 20, 2025 |
Performance
IMCV had a total return of 25.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.03%.
